Acupuncture significantly reduces joint pain for breast cancer patients
(SWOG) In the largest, most rigorous study of its kind, acupuncture was found to significantly reduce the debilitating joint pain experienced by tens of thousands of women each year while being treated for early stage breast cancer, according to SWOG research results to be announced at a Dec. 7 press conference at the San Antonio Breast Cancer Symposium.
Conclusions: Acupuncture improved symptoms of CIPN and QoL in Korean women suffering from peripheral neuropathy after chemotherapy using taxane for breast cancer. The effects of acupuncture lasted for at least 1 month after the treatment. PMID: 30420895 [PubMed]
In this Medical News article, an author and the editor of aJAMA research article on acupuncture for aromatase inhibitor –related pain in women with breast cancer discuss the article’s evolution and implications.
MONDAY, July 30, 2018 -- Acupuncture may cut joint pain among postmenopausal women with early-stage breast cancer and aromatase inhibitor-related pain, according to a study published in the July 10 issue of the Journal of the American Medical...
In a new study, researchers asked whether acupuncture might ease the joint pain associated with a drug used to treat early breast cancer.
(JAMA Network) Treatment for breast cancer with aromatase inhibitors often results in joint pain, which can contribute to treatment nonadherence. Several small studies have suggested that acupuncture may decrease aromatase inhibitor-related joint pain.
This randomized clinical trial compares true acupuncture with sham acupuncture and with waitlist control on the reduction of joint pain related to aromatase inhibitor use in postmenopausal women with early-stage breast cancer.
Abstract Purpose The Society for Integrative Oncology (SIO) produced an evidence-based guideline on use of integrative therapies during and after breast cancer treatment that was determined to be relevant to the American Society of Clinical Oncology (ASCO) membership. ASCO considered the guideline for endorsement. Methods The SIO guideline addressed the use of integrative therapies for the management of symptoms and adverse effects, such as anxiety and stress, mood disorders, fatigue, quality of life, chemotherapy-induced nausea and vomiting, lymphedema, chemotherapy-induced peripheral neuropathy, pain, and sleep ...
CONCLUSION: We found similar rates of preference for acupuncture versus medication among breast cancer survivors for pain management. Specific attitudes and beliefs predicted such preferences, highlighting the importance of a patient-centred approach to align patient beliefs and preferences with therapeutic options for more effective pain management. TRIAL REGISTRATION NUMBER: NCT01013337; Results. PMID: 29440043 [PubMed - as supplied by publisher]
In a randomized controlled trial that was praised as well designed, acupuncture improved pain and stiffness among breast cancer patients taking aromatase inhibitors (AIs).Medscape Medical News